Literature DB >> 9667242

Body-surface area as a basis for dosing of anticancer agents: science, myth, or habit?

M J Ratain.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9667242     DOI： 10.1200/JCO.1998.16.7.2297

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  38 in total

Review 1.  Modelling and simulation in the development and use of anti-cancer agents: an underused tool?

Authors:  Ferdinand Rombout; Leon Aarons; Mats Karlsson; Anthony Man; France Mentré; Peter Nygren; Amy Racine; Hans Schaefer; Jean-Louis Steimer; Iñaki Troconiz; Achiel van Peer
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-12       Impact factor: 2.745

2.  Body Composition as a Predictor of Toxicity in Patients Receiving Anthracycline and Taxane-Based Chemotherapy for Early-Stage Breast Cancer.

Authors:  Shlomit Strulov Shachar; Allison M Deal; Marc Weinberg; Grant R Williams; Kirsten A Nyrop; Karteek Popuri; Seul Ki Choi; Hyman B Muss
Journal:  Clin Cancer Res       Date:  2017-01-31       Impact factor: 12.531

3.  Prognostic significance of neutropenia during adjuvant concurrent chemoradiotherapy in early cervical cancer.

Authors:  Yun Hwan Kim; Hyun Hoon Chung; Jae Weon Kim; Noh-Hyun Park; Yong-Sang Song; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2009-09-30       Impact factor: 4.401

4.  Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy.

Authors:  Shlomit Strulov Shachar; Allison M Deal; Marc Weinberg; Kirsten A Nyrop; Grant R Williams; Tomohiro F Nishijima; Julia M Benbow; Hyman B Muss
Journal:  Clin Cancer Res       Date:  2016-08-03       Impact factor: 12.531

5.  HIPEC Methodology and Regimens: The Need for an Expert Consensus.

Authors:  Aditi Bhatt; Ignace de Hingh; Kurt Van Der Speeten; Martin Hubner; Marcello Deraco; Naoual Bakrin; Laurent Villeneuve; Shigeki Kusamura; Olivier Glehen
Journal:  Ann Surg Oncol       Date:  2021-06-17       Impact factor: 5.344

6.  Factors affecting the pharmacokinetic profile of MS-275, a novel histone deacetylase inhibitor, in patients with cancer.

Authors:  Milin R Acharya; Judith E Karp; Edward A Sausville; Kyunghwa Hwang; Qin Ryan; Ivana Gojo; Jurgen Venitz; William D Figg; Alex Sparreboom
Journal:  Invest New Drugs       Date:  2006-09       Impact factor: 3.850

7.  Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer.

Authors:  Michelle A Rudek; Roisin M Connolly; Janelle M Hoskins; Elizabeth Garrett-Mayer; Stacie C Jeter; Deborah K Armstrong; John H Fetting; Vered Stearns; Laurie A Wright; Ming Zhao; Stanley P Watkins; Howard L McLeod; Nancy E Davidson; Antonio C Wolff
Journal:  Breast Cancer Res Treat       Date:  2013-04-16       Impact factor: 4.872

8.  The average body surface area of adult cancer patients in the UK: a multicentre retrospective study.

Authors:  Joseph J Sacco; Joanne Botten; Fergus Macbeth; Adrian Bagust; Peter Clark
Journal:  PLoS One       Date:  2010-01-28       Impact factor: 3.240

Review 9.  Chemotherapy individualization.

Authors:  Gareth J Veal; Sally A Coulthard; Alan V Boddy
Journal:  Invest New Drugs       Date:  2003-05       Impact factor: 3.850

Review 10.  Practical treatment guide for dose individualisation in cancer chemotherapy.

Authors:  P Canal; E Chatelut; S Guichard
Journal:  Drugs       Date:  1998-12       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.